Abstract
Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation, is a common occurrence especially in preterm neonates. It is due to immaturity of the central nervous system (apnea of prematurity) or secondary to other causes such as metabolic disturbances etc. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylxanthines and continuous positive airway pressure form the mainstay of treatment. Mechanical ventilation is reserved for apnea resistant to the above therapy. An approach to the management of apnea in neonates is described.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hunt CE. Apnea and sudden infant death syndrome. In Kligman RM, Neider ML, Super DM, eds. Practical strategiesin pediatric diagnosis and therapy. Philadelphia; WB Saunders, 1996: 135–147.
Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr 2000; 39: 327–336.
Thompson MW, Hunt CE. In MacDonald MG, Mullett MD, Seshia MMK, eds. Avery’s Neonatology Pathophysiology & Management of the Newborn 6th ed. Philadelphia; Lippincott Williams and Wilkins, 1998; 539–545.
Martin RJ, Abu-Shaweesh, Baird TM. Pathophysiologic Mechanisms Underlying Apnea of Prematurity. Neo Reviews 2002; 3: e59.
Deorari AK. In Deorari AK, Paul VK, eds. Neonatal Equipment Everything that you like to know 3rd ed. New Delhi; Sagar Publication, 2006; 60–61.
Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev 2000.
Henderson-Smart DJ, Steer P. Prophylactic methylxanthine for extubation in preterm infants. Cochrane Database Syst Rev 2004.
Martin RJ, Abu-Shaweesh, Baird TM. Clinical Associations, Treatment, and Outcome of Apnea of Prematurity. Neo Reviews 2002; 3: e66.
Miller MJ, Martin RJ. Apnea of prematurity. Clin Perinatol 1992; 19: 789–808.
Henderson-Smart DJ, Steer PA. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database Syst Rev 2006.
Henderson-Smart DJ, Steer PA. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev 2004.
Hansen T, Corbet A. Control of breathing. In Taeusch HW, Ballard RA, eds. Avery’s diseases of the newborn, 7th ed. Philadelphia, WB Saunders, 1998; 552–561.
Jardine DS, Rogers K. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in premature infants. Pediatrics; 83: 721.
Kumar M, Kabra NS, Paes B. Carnitine supplementation for preterm infants with recurrent apnea. Cochrane Database Syst Rev 2004.
Henderson-Smart DJ, Subramanian P, Davis PG. Continuous positive airway pressure versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2005.
Davis PG, Henderson-Smart DJ. Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003.
Osborn DA, Henderson-Smart DJ, Kinesthetic stimulation for treating apnea in preterm infants. Cochrane Database Syst Rev 2003.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mishra, S., Agarwal, R., Jeevasankar, M. et al. Apnea in the newborn. Indian J Pediatr 75, 57–61 (2008). https://doi.org/10.1007/s12098-008-0008-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-008-0008-7